Alpha-Synuclein Pet Tracers To Detect Parkinsons Disease

Alpha-synuclein PET tracers to detect Parkinson’s disease

AD/PD highlights: α-synuclein PET tracer

The promise of 4R tau-PET tracer development

Misfolded alpha synuclein protein key to early detection of Parkinson’s disease Study

Medical Dialogues

Novel a-syn PET tracer shows promise for diagnosis and monitoring in synucleinopathies

Peripheral α-synuclein as a Parkinson’s disease biomarker

An update on biomarkers for use in Parkinson’s Disease

Advancing neuroimaging capabilities: visualizing tau and α-synuclein in parkinsonian syndromes

Alphasynuclein and their role in Parkinson's

Glycation of α-synuclein in Parkinson’s disease

Synapse with accumulating alpha-synuclein fibres

Investigating α-synuclein aggregation as a therapeutic target in Parkinson’s disease

Updates on α-synuclein as a biomarker in Parkinson's disease

Prasinezumab: an anti-alpha-synuclein antibody in Parkinson's disease

Advances in alpha-synuclein as a biomarker for Parkinson's disease

α-synuclein seed amplification assay for diagnosing Parkinson's disease

Is α-synuclein a useful therapeutic target in Parkinson's disease?

Is α-synuclein aggregation a cause or consequence of Parkinson’s disease?

Alpha-Synuclein and Parkinson’s disease: Part 2

Gates Brain Health

α-synuclein conformation as a novel blood biomarker in Parkinson’s disease